Factbox-Fat, not muscle: drugmakers in race for next weight-loss breakthrough
The U.S. drugmaker spent nearly $2 billion in 2023 to acquire Versanis Bio's bimagrumab, which prevents the activity of a ...
Zepbound for Weight Loss
The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...